Adamis Pharmaceuticals Corporation (NASDAQ:ADMP)

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP)


Share Price
$ 1.27
Change
0.02 (1.60 %)
Market Cap
$59.07 m
Proactive Investors - Run By Investors For Investors

Adamis Pharmaceuticals Corporation

Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas, including respiratory disease and allergy. The company’s Symjepi (epinephrine) Injection 0.3mg and Symjepi (epinephrine) Injection 0.15 mg products were approved for use in the emergency treatment of acute allergic reactions,...

EPIC: ADMP
Market: NASDAQ:ADMP
52-week High/Low: $4.25 / $1.18
Sector: Pharmaceuticals
Market Cap: $59.07 m
Website: www.adamispharmaceuticals.com
col 3
col 4
col 5
col 6

Adamis Pharmaceuticals Corporation Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use